Predictors of new-onset heart failure and overall survival in metastatic breast cancer patients treated with liposomal doxorubicin.

Sci Rep · 2020 · PMC7595106 · PMID 33116159

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

of borderline significancep = 0.08so close (0.05 < p ≤ 0.1)

Previous conventional doxorubicin therapy in a palliative setting was of borderline significance (HR 3.23; 95% CI 0.87–12.02; p = 0.08) even with a cumulative dose ≥ 400 mg/m2 (HR 4.26; 95% CI 0.91–19.79; p = 0.06).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.